Company / Operating Income per Share
CAPRICOR THERAPEUTICS, INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.88
FY2025
5-year range
-$1.88 / -$0.77
FY2021-FY2025
Trend
-101.9%
vs FY2024
Sector context
#117 of 201
Health Care
What the data says
At $-1.88, CAPRICOR THERAPEUTICS, INC.'s operating income per share ranks #117 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-4.88 in FY2019 to $-0.49 in FY2018.
Based on SEC 10-K filings.
-1.88 in FY2025.
Declined from $-0.77 to $-1.88 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#117 of 201 in Health CareTop 58% of 201This company -$1.88 Sector average -$28.51
▼
+93.4% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 101.9% year-over-year.
- Ranks #117 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2018.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.88 | -101.9% |
| FY2024 | -$0.93 | -20.8% |
| FY2023 | -$0.77 | +34.3% |
| FY2022 | -$1.18 | -35.9% |
| FY2021 | -$0.87 | -30.1% |
| FY2020 | -$0.67 | +86.4% |
| FY2019 | -$4.88 | -900.0% |
| FY2018 | -$0.49 | +0.3% |
| FY2017 | -$0.49 | +38.3% |
| FY2016 | -$0.79 | -2.3% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026